In this article, we review current trials of aromatase inhibitors in the adjuvant setting and the clinical implications for patients with early breast cancer.

Purpose. The clinical and economic benefits of aromatase inhibitor (AI) therapy in early-stage breast cancer are reviewed. Summary. AI therapy has become a standard of care for the treatment of ...